<!doctype html><html class=no-js lang=en><head><meta charset=UTF-8><meta name=viewport content="width=device-width,initial-scale=1"><title>ç§‘ç ”æ—¥æŠ¥ 2025-12-30 - ç”Ÿä¿¡æ™®æ‹‰æ–¯</title>
<script>(function(e,t){e[t]=e[t].replace("no-js","js")})(document.documentElement,"className")</script><meta name=description content><meta property="og:url" content="https://ixxmu.github.io/posts/dailyreports/2025-12-30/"><meta property="og:site_name" content="ç”Ÿä¿¡æ™®æ‹‰æ–¯"><meta property="og:title" content="ç§‘ç ”æ—¥æŠ¥ 2025-12-30"><meta property="og:description" content="ğŸ“… Daily Report - 2025-12-30 ä»Šæ—¥ç­›é€‰å‡º 9 æ¡å†…å®¹ï¼Œæ¥è‡ª 3 ä¸ªæ¥æº"><meta property="og:locale" content="zh_cn"><meta property="og:type" content="article"><meta property="article:section" content="posts"><meta property="article:published_time" content="2025-12-30T00:00:00+00:00"><meta property="article:modified_time" content="2025-12-30T00:00:00+00:00"><meta property="article:tag" content="Research"><meta property="article:tag" content="Daily"><meta property="article:tag" content="Week532025"><meta itemprop=name content="ç§‘ç ”æ—¥æŠ¥ 2025-12-30"><meta itemprop=description content="ğŸ“… Daily Report - 2025-12-30 ä»Šæ—¥ç­›é€‰å‡º 9 æ¡å†…å®¹ï¼Œæ¥è‡ª 3 ä¸ªæ¥æº"><meta itemprop=datePublished content="2025-12-30T00:00:00+00:00"><meta itemprop=dateModified content="2025-12-30T00:00:00+00:00"><meta itemprop=wordCount content="1524"><meta itemprop=keywords content="Research,Daily,Week532025"><meta name=twitter:card content="summary"><meta name=twitter:title content="ç§‘ç ”æ—¥æŠ¥ 2025-12-30"><meta name=twitter:description content="ğŸ“… Daily Report - 2025-12-30 ä»Šæ—¥ç­›é€‰å‡º 9 æ¡å†…å®¹ï¼Œæ¥è‡ª 3 ä¸ªæ¥æº"><link rel=preconnect href=https://fonts.gstatic.com crossorigin><link rel=dns-prefetch href=//fonts.googleapis.com><link rel=dns-prefetch href=//fonts.gstatic.com><link rel=stylesheet href="https://fonts.googleapis.com/css?family=Open+Sans:400,400i,700"><link rel=stylesheet href=../../../css/style.css><link rel=stylesheet href=../../../css/custom.css><link rel="shortcut icon" href=../../../favicon.ico></head><body class=body><div class="container container--outer"><header class=header><div class="container header__container"><div class=logo><a class=logo__link href=../../../ title=ç”Ÿä¿¡æ™®æ‹‰æ–¯ rel=home><div class="logo__item logo__text"><div class=logo__title>ç”Ÿä¿¡æ™®æ‹‰æ–¯</div><div class=logo__tagline>è¿‘åå¹´æœ€å€¼å¾—ä¸Šæ‰‹çš„ç”Ÿç‰©åŒ»å­¦ç”Ÿä¿¡ä»£ç </div></div></a></div><nav class=menu><button class=menu__btn aria-haspopup=true aria-expanded=false tabindex=0>
<span class=menu__btn-title tabindex=-1>Menu</span></button><ul class=menu__list><li class=menu__item><a class=menu__link href=../../../posts/><span class=menu__text>æ–‡ç« </span></a></li><li class=menu__item><a class=menu__link href=../../../tags/><span class=menu__text>æ ‡ç­¾</span></a></li><li class=menu__item><a class=menu__link href=../../../about/><span class=menu__text>å…³äº</span></a></li></ul></nav></div></header><div class="wrapper flex"><div class=primary><main class=main role=main><article class=post><header class=post__header><meta name=referrer content="never"><h1 class=post__title>ç§‘ç ”æ—¥æŠ¥ 2025-12-30</h1><div class="post__meta meta"><div class="meta__item-datetime meta__item"><svg class="meta__icon icon icon-time" width="16" height="14" viewBox="0 0 30 28"><path d="M15 0a14 14 0 110 28 1 1 0 010-28m0 3a3 3 0 100 22 3 3 0 000-22m1 4h-2v8.4l6.8 4.4L22 18l-6-3.8z"/></svg><time class=meta__text datetime=2025-12-30T00:00:00Z>2025-12-30</time></div><div class="meta__item-categories meta__item"><svg class="meta__icon icon icon-category" width="16" height="16" viewBox="0 0 16 16"><path d="m7 2 1 2h8v11H0V2z"/></svg><span class=meta__text><a class=meta__link href=../../../categories/dailyreport/ rel=category>DailyReport</a></span></div><div class="meta__item-author meta__item"><svg class="meta__icon icon icon-author" width="16" height="16" viewBox="0 0 16 16"><path d="M8 1c2 0 3.5 2 3.5 4.5S10 9 10 9c3 1 4 2 4 6H2c0-4 1-5 4-6 0 0-1.5-1-1.5-3.5S6 1 8 1"/></svg><span class=meta__text>Bloger</span></div></div></header><div class="post__toc toc"><div class=toc__title>Page content</div><div class=toc__menu><nav id=TableOfContents><ul><li><a href=#-ä»Šæ—¥aiæ™ºèƒ½æ€»ç»“>ğŸ¤– ä»Šæ—¥AIæ™ºèƒ½æ€»ç»“</a><ul><li><a href=#-æ•°æ®å‰æ²¿>ğŸ§¬ æ•°æ®å‰æ²¿</a></li><li><a href=#-å­¦ç‚¹ç”Ÿä¿¡>ğŸ“Š å­¦ç‚¹ç”Ÿä¿¡</a></li><li><a href=#-åšå®¢æ›´æ–°>ğŸ§ª åšå®¢æ›´æ–°</a></li></ul></li><li><a href=#-åˆ†ç±»æµè§ˆ>ğŸ“š åˆ†ç±»æµè§ˆ</a><ul><li></li></ul></li><li><a href=#-å…³é”®è¯ç»Ÿè®¡>ğŸ“Š å…³é”®è¯ç»Ÿè®¡</a></li></ul></nav></div></div><div class="content post__content clearfix"><h1 id=-daily-report---2025-12-30>ğŸ“… Daily Report - 2025-12-30</h1><blockquote><p>ä»Šæ—¥ç­›é€‰å‡º <strong>9</strong> æ¡å†…å®¹ï¼Œæ¥è‡ª <strong>3</strong> ä¸ªæ¥æº</p></blockquote><div class=powered-by-top>Powered by <a href=https://kyplus.de>ç§‘ç ”æ™®æ‹‰æ–¯</a> & <a href=https://claude.ai>Claude</a></div><hr><h2 id=-ä»Šæ—¥aiæ™ºèƒ½æ€»ç»“>ğŸ¤– ä»Šæ—¥AIæ™ºèƒ½æ€»ç»“</h2><h3 id=-æ•°æ®å‰æ²¿>ğŸ§¬ æ•°æ®å‰æ²¿</h3><blockquote><p><strong>ä»Šæ—¥ç„¦ç‚¹</strong>ï¼š
zebrafishæ¨¡å‹ä¸­CRATERè‚¿ç˜¤å¾®ç¯å¢ƒä¿ƒè¿›CD8+ Tç»†èƒæµ¸æ¶¦ï¼Œé¢„ç¤ºå…ç–«æ²»ç–—æˆåŠŸï¼›CXCR4 S338Xå˜å¼‚å¢å¼ºCAR-Tç»†èƒæŠ—ç™½è¡€ç—…ç–—æ•ˆã€‚</p></blockquote><p><strong>ä¸»è¦æ–¹å‘</strong>ï¼š</p><ul><li>è‚¿ç˜¤å…ç–«å­¦ï¼šç ”ç©¶è‚¿ç˜¤å¾®ç¯å¢ƒå¯¹å…ç–«ç»†èƒæ´»æ€§çš„è°ƒæ§åŠå…¶ä¸å…ç–«æ²»ç–—å“åº”çš„å…³ç³»ã€‚</li><li>ç»†èƒæ²»ç–—ï¼šå¼€å‘æ–°å‹CAR-Tç»†èƒç­–ç•¥ï¼Œæé«˜å…¶åœ¨è¡€æ¶²è‚¿ç˜¤æ²»ç–—ä¸­çš„ç–—æ•ˆã€‚</li><li>ä¿¡å·é€šè·¯è°ƒæ§ï¼šæ¢ç©¶Wntä¿¡å·åœ¨èƒƒéƒ¨ç»†èƒåˆ†åŒ–åŠè§†é»„é†‡ä»£è°¢ä¸­çš„ä½œç”¨ã€‚</li><li>DNAæŸä¼¤ä¿®å¤ï¼šé˜æ˜DOT1Lä»‹å¯¼çš„CDK9ç”²åŸºåŒ–åœ¨DNAåŒé“¾æ–­è£‚ä¿®å¤ä¸­çš„å…³é”®ä½œç”¨ã€‚</li></ul><p><strong>æŠ€æœ¯äº®ç‚¹</strong>ï¼š</p><ul><li>ç©ºé—´è½¬å½•ç»„å­¦ï¼šæ­ç¤ºè‚¿ç˜¤å¾®ç¯å¢ƒä¸­ç»†èƒé—´çš„ç©ºé—´äº’ä½œã€‚</li><li>é«˜é€šé‡æµ‹åºæŠ€æœ¯ï¼šå¹¿æ³›åº”ç”¨äºåŸºå› è¡¨è¾¾ã€æŸ“è‰²è´¨ç»“åˆç­‰ç ”ç©¶ã€‚</li></ul><h3 id=-å­¦ç‚¹ç”Ÿä¿¡>ğŸ“Š å­¦ç‚¹ç”Ÿä¿¡</h3><blockquote><p><strong>ä»Šæ—¥ç„¦ç‚¹</strong>ï¼š
å°†å›¾ç¥ç»ç½‘ç»œï¼ˆGNNsï¼‰ã€åµŒå…¥ï¼ˆembeddingsï¼‰å’ŒåŸºç¡€æ¨¡å‹ï¼ˆfoundation modelsï¼‰æ•´åˆåº”ç”¨äºç©ºé—´æ•°æ®ç§‘å­¦ï¼Œä¸ºå¤„ç†å¤æ‚ç©ºé—´å…³ç³»å’Œå¤§è§„æ¨¡æ•°æ®é›†æä¾›äº†æ–°å‹æ·±åº¦å­¦ä¹ æ¡†æ¶ã€‚</p></blockquote><p><strong>ä¸»è¦æ–¹å‘</strong>ï¼š</p><ul><li>åˆ©ç”¨GNNsæ•æ‰ç©ºé—´æ•°æ®çš„æ‹“æ‰‘å’Œå‡ ä½•å…³ç³»ã€‚</li><li>å¼€å‘é€‚ç”¨äºç©ºé—´æ•°æ®çš„åµŒå…¥æŠ€æœ¯ï¼Œä»¥è¡¨ç¤ºå’Œå­¦ä¹ å…¶æ½œåœ¨ç‰¹å¾ã€‚</li><li>æ¢ç´¢åŸºç¡€æ¨¡å‹åœ¨ç©ºé—´æ•°æ®åˆ†æä¸­çš„æ½œåŠ›ã€‚</li></ul><p><strong>æŠ€æœ¯äº®ç‚¹</strong>ï¼š</p><ul><li>GNNsåœ¨ç©ºé—´æ•°æ®ç§‘å­¦ä¸­çš„åˆ›æ–°åº”ç”¨ã€‚</li><li>æ·±åº¦å­¦ä¹ æ¦‚å¿µï¼ˆGNNs, embeddings, foundation modelsï¼‰çš„é›†æˆã€‚</li></ul><h3 id=-åšå®¢æ›´æ–°>ğŸ§ª åšå®¢æ›´æ–°</h3><blockquote><p><strong>ä»Šæ—¥ç„¦ç‚¹</strong>ï¼š
SARS-CoV-2æ„ŸæŸ“æ˜¾è‘—æ”¹å˜è‚ºç»†èƒlncRNAsçš„RNAç”²åŸºåŒ–ï¼Œä¸ºç—…æ¯’æ„ŸæŸ“æœºåˆ¶å’Œå®¿ä¸»ååº”æä¾›æ–°è§†è§’ã€‚</p></blockquote><p><strong>ä¸»è¦æ–¹å‘</strong>ï¼š</p><ul><li>ç—…æ¯’æ„ŸæŸ“å¯¹å®¿ä¸»RNAè°ƒæ§çš„å½±å“ã€‚</li><li>åˆ©ç”¨RNAç”Ÿç‰©æ ‡å¿—ç‰©è¿›è¡Œæ—©æœŸè‚ºç™Œè¯Šæ–­ã€‚</li><li>çº¿ç²’ä½“DNAï¼ˆâ€œå¦ä¸€â€åŸºå› ç»„ï¼‰çš„ç»“æ„ä¸åŠŸèƒ½è§£æã€‚</li></ul><p><strong>æŠ€æœ¯äº®ç‚¹</strong>ï¼š</p><ul><li>ç›´æ¥RNAæµ‹åºæŠ€æœ¯åœ¨æ¶²ä½“æ´»æ£€ä¸­çš„åº”ç”¨ã€‚</li><li>æ­ç¤ºçº¿ç²’ä½“DNAçš„æ¼”åŒ–èµ·æºã€‚</li></ul><hr><h2 id=-åˆ†ç±»æµè§ˆ>ğŸ“š åˆ†ç±»æµè§ˆ</h2><details><summary style="text-align:right;direction:rtl;padding:10px 15px;background:linear-gradient(135deg,#f8f9fa 0%,#e9ecef 100%);border-right:4px solid #667eea;font-weight:600;cursor:pointer;margin:15px 0;border-radius:6px">ğŸ§¬ æ•°æ®å‰æ²¿ (5æ¡)</summary><div class=details-content markdown=1><h4 id=è¯¦ç»†å†…å®¹å…¨éƒ¨5æ¡>è¯¦ç»†å†…å®¹ï¼ˆå…¨éƒ¨5æ¡ï¼‰</h4><p><strong>1.</strong> â­ <strong>GSE312604 CRATER è‚¿ç˜¤å¾®ç¯å¢ƒä¿ƒè¿› CD8+ T ç»†èƒå‚ä¸å¹¶ä¸å…ç–«æ²»ç–—æˆåŠŸç›¸å…³ [ç©ºé—´è½¬å½•ç»„å­¦]</strong></p><ul><li>âœï¸ <strong>ä½œè€…</strong>ï¼šæœªçŸ¥ä½œè€…</li><li>ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼štumorã€T cellã€regex:immuno(logy|therapy|suppression)ã€spatialã€spatial transcriptomicsã€transcriptomics</li><li>ğŸ“ <strong>æè¿°</strong>ï¼šContributors : Georgia Stirts ; Sophia Liu ; Qiyu Gong ; Irving Barrera ; Aya Ludin ; Leonard Zon ; Fei ChenSeries Type : OtherOrganism : Danio rerioT cell-mediated tumor killing underlies immunotherapy success. Here, we used long-term in vivo imaging and high-resolution spatial transcriptomics of zebrafish endogenous melanoma, as well as multiplex imaging of human melanoma, to identify domains facilitating the immune response during immunotherapy. We identified cancer regions of antigen presentation and T cell engagement and retention (CRATERs) as pockets at the stroma-melanocyte boundaries of zebrafish and human melanoma. CRATERs are rich in antigen-recognition molecules, harboring the highest density of CD8+ T cells in tumors. In zebrafish, CD8+ T cells formed prolonged interactions with melanoma cells within CRATERs, characteristic of antigen recognition. Following immunostimulatory treatment, CRATERs expanded, becoming the major sites of activated CD8+ T cell accumulation and tumor killing. In humans, elevation in CRATER density in biopsies following immune checkpoint blockade (ICB) therapy correlated with a clinical response to therapy. CRATERs are structures that show active tumor killing and may be useful as a diagnostic indicator for immunotherapy success.</li><li>ğŸ”— <a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE312604">æŸ¥çœ‹åŸæ–‡</a></li></ul><p><strong>2.</strong> <strong>GSE307141 ç ”ç©¶æŠ—æ°§åŒ–å‰‚è¡¨æ²¡é£Ÿå­å„¿èŒ¶ç´ æ²¡é£Ÿå­é…¸é…¯åœ¨èƒå„¿é…’ç²¾è°±ç³»éšœç¢ä¸­çš„æ²»ç–—æ½œåŠ›ï¼šè®¤çŸ¥å’ŒRNAæµ‹åº</strong></p><ul><li>âœï¸ <strong>ä½œè€…</strong>ï¼šæœªçŸ¥ä½œè€…</li><li>ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼šRNAseq</li><li>ğŸ“ <strong>æè¿°</strong>ï¼šContributors : Anna Ramos-Triguero ; Marta Astals-Vizcaino ; Elisabet Navarro-Tapia ; Melina Vieiros ; Adriana Bastons-Compta ; Leopoldo MartÃ­nez ; Vicente Andreu-FernÃ¡ndez ; Ã“scar GarcÃ­a-AlgarSeries Type : Expression profiling by high throughput sequencingOrganism : Homo sapiensPrenatal alcohol exposure (PAE) impacts fetal development, leading to Fetal Alcohol Spectrum Disorders (FASD) characterized by cognitive, behavioral, and physical impairments. This study explores Epigallocatechin Gallate (EGCG), a potent antioxidant and modulator of neuronal plasticity, as a therapeutic intervention for FASD improvement. In a 12-month pilot study, patients with 40 FASD received 9 mg/kg/day of EGCG, with outcomes assessed through RNA sequencing of blood samples and neurocognitive evaluations (WISC-IV, CBCL 6-18, and NEPSY-II). Reduced levels of oxidative stress were observed after 6 months of daily treatment with EGCG, to maintain the bioavailability of the molecule in the body, with decreased levels of MDA and 8-isoprostane and increased activity of LDH. Significant neurocognitive improvements were shown after one year of treatment in Perceptual Reasoning Index (PRI) and Working Memory Index (WMI) using the WISC-IV test. CBCL test revealed an improvement in aggressive behavior scores after EGCG treatment. NEPSY-II assessment showed improvements in face memory, and delayed face memory. Interestingly, no significant improvements were observed in intelligence quotient, attention, anxiety, or depression, which affect a proportion of individuals diagnosed with FASD. Additionally, EGCG modulates molecular pathways associated with neuroinflammation, oxidative stress, immune response, and neurogenesis. This study highlights EGCG as a potential therapeutic candidate to ameliorate cognitive and behavioral deficits caused by PAE in children affected by FASD, revealing potential pathways and biomarkers that contribute to these improvements. These advancements ultimately aim to enhance the quality of life for FASD patients and their families.</li><li>ğŸ”— <a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE307141">æŸ¥çœ‹åŸæ–‡</a></li></ul><p><strong>3.</strong> <strong>GSE314992 CXCR4 S338X å˜ä½“çš„è¡¨è¾¾æé«˜äº†æŠ— CD19 CAR-T ç»†èƒçš„æŠ—ç™½è¡€ç—…ç–—æ•ˆ</strong></p><ul><li>âœï¸ <strong>ä½œè€…</strong>ï¼šæœªçŸ¥ä½œè€…</li><li>ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼šleukemia</li><li>ğŸ“ <strong>æè¿°</strong>ï¼šContributors : Yushu Mao ; Zheng Hu ; Yong-guang YangSeries Type : Expression profiling by high throughput sequencingOrganism : Homo sapiensChimeric antigen receptor T (CAR-T) cell therapy has demonstrated remarkable success in treating hematological malignancies; however, antigen-positive relapse remains a significant obstacle to achieving sustained remission in B-cell acute lymphoblastic leukemia (B-ALL). To enhance the therapeutic efficacy of anti-CD19 CAR (CAR19)-T cells, we overexpressed CXCR4 in CAR19-T cells to improve their trafficking to bone marrow (BM), a key sanctuary for minimal residual disease. We engineered CAR19-T cells with overexpression of wild-type CXCR4 (CAR19/CXCR4WT-T) or gain-of-function CXCR4 S338X mutant (CAR19/CXCR4S338X-T). Both CAR19/CXCR4WT-T and CAR19/CXCR4S338X-T cells exhibited enhanced CXCR4 surface expression in vitro and in vivo compared to control CAR19-T cells, with the latter showing significantly superior improvements under all tested conditions, including engagement with CAR-specific antigens or CXCR4 ligand CXCL12. Upon engagement with CXCL12, CAR19/CXCR4S338X-T cells, but not CAR19/CXCR4WT-T cells, displayed significantly increased activation of ERK1/2 and AKT signaling pathways, as well as elevated transcription of TNF-Î±, IFN-Î³, granzyme B, CDK6, and BCL2A1, along with strengthened effector functions, chemotaxis, and activation of anti-apoptotic pathways. Furthermore, CAR19/CXCR4S338X-T cells demonstrated significantly improved migration to and retention in the BM accompanied by increased CD45RA+CCR7+ memory T cell populations, which correlated with enhanced anti-leukemic effects following injection into B-ALL-bearing mice. This study offers a potentially effective strategy to improve the functionality and durability of CAR-T cell responses in hematological malignancies.</li><li>ğŸ”— <a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE314992">æŸ¥çœ‹åŸæ–‡</a></li></ul><p><strong>4.</strong> <strong>GSE314919 Wnt è°ƒæ§å°é¼ èƒƒç»†èƒåˆ†åŒ–å’Œç±»è§†é»„é†‡ä»£è°¢åŸºå› </strong></p><ul><li>âœï¸ <strong>ä½œè€…</strong>ï¼šæœªçŸ¥ä½œè€…</li><li>ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼šmetabolism</li><li>ğŸ“ <strong>æè¿°</strong>ï¼šContributors : Elizabeth Delgado ; Elise S Hibdon ; Theresa M Keeley ; Christopher Q Huynh ; Justin A Colacino ; Linda C SamuelsonSeries Type : Expression profiling by high throughput sequencingOrganism : Mus musculusBackground & Aims: While recognized as a key regulator of gastrointestinal tissues, Wnt function in the stomach is poorly understood. This study aimed to define Wnt functions and identify Wnt-regulated genes in the stomach. Methods: Wnt signaling was localized using reporter mice. Proliferation was studied after canonical Wnt inhibition in vivo using Sox2-CreERT2; Ctnnb1fl/fl mice and in vitro using gastric organoid cultures. Wnt-regulated genes and potential effector pathways were identified by bulk RNAseq analysis of corpus and antral organoids 24 hours after Wnt inhibition. Retinoid metabolic components were localized in control and Wnt-inhibited mouse stomach by immunostaining. Results: Wnt signaling cells mapped to the base and proliferative region in both corpus and antrum. Wnt inhibition in vivo reduced proliferation and led to gastric stem cell loss. Cell signature analysis of RNAseq data revealed that gastric organoids adopt a surface cell transcriptional profile following Wnt inhibition instead of a basal cell profile. Furthermore, retinoid metabolism terms were differentially expressed after Wnt inhibition, with both corpus and antrum displaying decreased expression of retinoic acid target genes. Immunostaining mouse stomach showed differential localization of retinoid metabolic components in luminal pit cells (ALDH3A1), and basal chief/deep mucous cells (STRA6), with expression changes after b-catenin deletion consistent with the organoid analysis. Conclusion: Wnt signaling is required for gastric stem cell survival and promotes differentiation of cell types at the gland base. Retinoid metabolism is a candidate Wnt-regulated pathway, with cell-specific expression of key components. Localization of the retinol transporter STRA6 to high-Wnt cells at the gland base suggests that they are retinoic acid signaling cells.</li><li>ğŸ”— <a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE314919">æŸ¥çœ‹åŸæ–‡</a></li></ul><p><strong>5.</strong> <strong>GSE314839 DOT1Lä»‹å¯¼çš„CDK9ç”²åŸºåŒ–å¯¹äºDNAåŒé“¾æ–­è£‚ä¿®å¤è‡³å…³é‡è¦</strong></p><ul><li>âœï¸ <strong>ä½œè€…</strong>ï¼šæœªçŸ¥ä½œè€…</li><li>ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼šmethylation</li><li>ğŸ“ <strong>æè¿°</strong>ï¼šContributors : Yugyeong Kim ; Hyebin Park ; Sang Beom SeoSeries Type : Genome binding/occupancy profiling by high throughput sequencingOrganism : Homo sapiensP-TEFb is a key regulator of transcription elongation and is composed of cyclin-dependent kinase 9 (CDK9) and cyclin T1. DOT1L is a histone H3K79 methyltransferase. Here, we show that treatment with the DOT1L inhibitor EPZ-5676 induces transcriptome changes in HCT116 cells. We further demonstrate that DOT1L methylates CDK9 at lysine 56 and that CDK9 methylation-deficient mutant K56A reshapes genome-wide CDK9 occupancy. Notably, changes in CDK9 occupancy are particularly pronounced at double-strand break (DSB)-related genes and are associated with the regulation of their transcription. This idataset includes RNA-seq and ChIP-seq data generated from HCT116 cells.</li><li>ğŸ”— <a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE314839">æŸ¥çœ‹åŸæ–‡</a></li></ul></div></details><details><summary style="text-align:right;direction:rtl;padding:10px 15px;background:linear-gradient(135deg,#f8f9fa 0%,#e9ecef 100%);border-right:4px solid #667eea;font-weight:600;cursor:pointer;margin:15px 0;border-radius:6px">ğŸ“Š å­¦ç‚¹ç”Ÿä¿¡ (1æ¡)</summary><div class=details-content markdown=1><h4 id=è¯¦ç»†å†…å®¹å…¨éƒ¨1æ¡>è¯¦ç»†å†…å®¹ï¼ˆå…¨éƒ¨1æ¡ï¼‰</h4><p><strong>1.</strong> <strong>æˆ¿é—´é‡Œçš„å¤§è±¡ï¼šç©ºé—´æ•°æ®ç§‘å­¦ä¸­çš„å›¾ç¥ç»ç½‘ç»œã€åµŒå…¥å’ŒåŸºç¡€æ¨¡å‹</strong></p><ul><li>âœï¸ <strong>ä½œè€…</strong>ï¼šæœªçŸ¥ä½œè€…</li><li>ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼šspatial</li><li>ğŸ“ <strong>æè¿°</strong>ï¼šSlides: <a href=https://jakubnowosad.com/agforum2025>https://jakubnowosad.com/agforum2025</a> This presentation covered three interconnected deep learning concepts appearing in spatial data science work. Graph Neural Networks (GNNs) are a deep learning architecture that represents spatial dat&mldr; Continue reading: Elephant(s) in the room: Graph neural networks, embeddings, and foundation models in spatial data science</li><li>ğŸ”— <a href=https://www.r-bloggers.com/2025/12/elephants-in-the-room-graph-neural-networks-embeddings-and-foundation-models-in-spatial-data-science/>æŸ¥çœ‹åŸæ–‡</a></li></ul></div></details><details><summary style="text-align:right;direction:rtl;padding:10px 15px;background:linear-gradient(135deg,#f8f9fa 0%,#e9ecef 100%);border-right:4px solid #667eea;font-weight:600;cursor:pointer;margin:15px 0;border-radius:6px">ğŸ§ª åšå®¢æ›´æ–° (3æ¡)</summary><div class=details-content markdown=1><h4 id=è¯¦ç»†å†…å®¹å…¨éƒ¨3æ¡>è¯¦ç»†å†…å®¹ï¼ˆå…¨éƒ¨3æ¡ï¼‰</h4><p><strong>1.</strong> <strong>SARS-CoV-2æ„ŸæŸ“æ”¹å˜è‚ºç»†èƒlncRNAçš„RNAç”²åŸºåŒ–</strong></p><ul><li>âœï¸ <strong>ä½œè€…</strong>ï¼šæœªçŸ¥ä½œè€…</li><li>ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼šmethylation</li><li>ğŸ“ <strong>æè¿°</strong>ï¼šWhen a virus infects a cell, it does more than just hijack the machinery to make new virus particles. It can also subtly reshape how the cell regulates its own RNA. Researchers from the Center for Medical Bioinformatics, Escola Paulista de Medicina, Federal University of SÃ£o Paulo (UNIFESP) explored this idea by looking at &mldr;</li><li>ğŸ”— <a href=https://www.rna-seqblog.com/sars-cov-2-infection-alters-rna-methylation-in-lung-cell-lncrnas/>æŸ¥çœ‹åŸæ–‡</a></li></ul><p><strong>2.</strong> <strong>Hummingbird Diagnosticså…¬å¸å‘è¡¨äº†å…³äºæ¶²ä½“æ´»æ£€ä¸­RNAç”Ÿç‰©æ ‡å¿—ç‰©ç”²åŸºåŒ–çš„ç ”ç©¶æŠ¥å‘Š</strong></p><ul><li>âœï¸ <strong>ä½œè€…</strong>ï¼šæœªçŸ¥ä½œè€…</li><li>ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼šmethylation</li><li>ğŸ“ <strong>æè¿°</strong>ï¼šRevealing a new layer in lung cancer diagnostics using direct RNA sequencing Hummingbird Diagnostics GmbH, a pioneer in harnessing blood-based small RNAs for early disease detection and characterization, today announced the publication of a new study in Nature Communications Medicine introducing an Oxford Nanopore Technologies (ONT)-based method for detecting small RNA modifications in blood The &mldr;</li><li>ğŸ”— <a href=https://www.rna-seqblog.com/hummingbird-diagnostics-publishes-study-on-rna-biomarker-methylation-in-liquid-biopsies/>æŸ¥çœ‹åŸæ–‡</a></li></ul><p><strong>3.</strong> <strong>æŠ€æœ¯è¿›æ­¥æ­å¼€äº†çº¿ç²’ä½“DNAä¹‹è°œâ€”â€”æˆ‘ä»¬çš„â€œå¦ä¸€ä¸ªâ€åŸºå› ç»„</strong></p><ul><li>âœï¸ <strong>ä½œè€…</strong>ï¼šæœªçŸ¥ä½œè€…</li><li>ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼šgenome</li><li>ğŸ“ <strong>æè¿°</strong>ï¼šAbout 1.8 billion years ago, one of our earliest ancestral cells engulfed a bacterial cell. Rather than being digested, the bacterium survived, and the two cells formed a partnership that persists to this day. Over time, that bacterium evolved into mitochondria, organelles found within cells whose role is echoed in science classrooms as being &mldr;</li><li>ğŸ”— <a href=https://www.rna-seqblog.com/technology-advances-unlock-the-mystery-of-mitochondrial-dna-our-other-genome/>æŸ¥çœ‹åŸæ–‡</a></li></ul></div></details><h2 id=-å…³é”®è¯ç»Ÿè®¡>ğŸ“Š å…³é”®è¯ç»Ÿè®¡</h2><table><thead><tr><th>å…³é”®è¯</th><th>å‡ºç°æ¬¡æ•°</th></tr></thead><tbody><tr><td>methylation</td><td>3</td></tr><tr><td>spatial</td><td>2</td></tr><tr><td>RNAseq</td><td>1</td></tr><tr><td>genome</td><td>1</td></tr><tr><td>leukemia</td><td>1</td></tr><tr><td>metabolism</td><td>1</td></tr><tr><td>tumor</td><td>1</td></tr><tr><td>T cell</td><td>1</td></tr><tr><td>regex:immuno(logy</td><td>therapy</td></tr><tr><td>spatial transcriptomics</td><td>1</td></tr><tr><td>transcriptomics</td><td>1</td></tr></tbody></table><hr><p><em>ğŸ“… æŠ¥å‘Šç”Ÿæˆæ—¶é—´ï¼š2025-12-29 21:37</em><br><em>ğŸ¤– ç”± GitHub Actions è‡ªåŠ¨ç”Ÿæˆ</em></p></div><footer class=post__footer><div class="post__tags tags clearfix"><svg class="tags__badge icon icon-tag" width="16" height="16" viewBox="0 0 32 32"><path d="M4 0h8s2 0 4 2l15 15s2 2 0 4L21 31s-2 2-4 0L2 16s-2-2-2-4V3s0-3 4-3m3 10a3 3 0 000-6 3 3 0 000 6"/></svg><ul class=tags__list><li class=tags__item><a class="tags__link btn" href=../../../tags/research/ rel=tag>Research</a></li><li class=tags__item><a class="tags__link btn" href=../../../tags/daily/ rel=tag>Daily</a></li><li class=tags__item><a class="tags__link btn" href=../../../tags/week532025/ rel=tag>Week532025</a></li></ul></div></footer></article></main><div class="authorbox clearfix"><div class=authorbox__header><span class=authorbox__name>About Bloger</span></div></div><nav class="pager flex"><div class="pager__item pager__item--prev"><a class=pager__link href=../../../posts/dailyreports/2025-12-29/ rel=prev><span class=pager__subtitle>Â«&#8201;Previous</span><p class=pager__title>ç§‘ç ”æ—¥æŠ¥ 2025-12-29</p></a></div><div class="pager__item pager__item--next"><a class=pager__link href=../../../posts/dailyreports/2025-12-31/ rel=next><span class=pager__subtitle>Next&#8201;Â»</span><p class=pager__title>ç§‘ç ”æ—¥æŠ¥ 2025-12-31</p></a></div></nav><section class=comments><div id=disqus_thread></div><script>window.disqus_config=function(){},function(){if(["localhost","127.0.0.1"].indexOf(window.location.hostname)!=-1){document.getElementById("disqus_thread").innerHTML="Disqus comments not available by default when the website is previewed locally.";return}var t=document,e=t.createElement("script");e.async=!0,e.src="//kkitown.disqus.com/embed.js",e.setAttribute("data-timestamp",+new Date),(t.head||t.body).appendChild(e)}()</script><noscript>Please enable JavaScript to view the <a href=https://disqus.com/?ref_noscript>comments powered by Disqus.</a></noscript><a href=https://disqus.com class=dsq-brlink>comments powered by <span class=logo-disqus>Disqus</span></a></section></div><aside class=sidebar><div class="widget-search widget"><form class=widget-search__form role=search method=get action=https://google.com/search><input class=widget-search__field type=search placeholder=Searchâ€¦ name=q aria-label=Searchâ€¦>
<input class=widget-search__submit type=submit value=Search>
<input type=hidden name=sitesearch value=https://ixxmu.github.io/></form></div><div class="widget-recent widget"><h4 class=widget__title>Recent Posts</h4><div class=widget__content><ul class=widget__list><li class=widget__item><a class=widget__link href=../../../posts/dailyreports/2026-01-05/>ç§‘ç ”æ—¥æŠ¥ 2026-01-05</a></li><li class=widget__item><a class=widget__link href=../../../posts/dailyreports/2026-01-04/>ç§‘ç ”æ—¥æŠ¥ 2026-01-04</a></li><li class=widget__item><a class=widget__link href=../../../posts/dailyreports/2026-01-03/>ç§‘ç ”æ—¥æŠ¥ 2026-01-03</a></li><li class=widget__item><a class=widget__link href=../../../posts/dailyreports/2026-01-02/>ç§‘ç ”æ—¥æŠ¥ 2026-01-02</a></li><li class=widget__item><a class=widget__link href=../../../posts/dailyreports/2026-01-01/>ç§‘ç ”æ—¥æŠ¥ 2026-01-01</a></li></ul></div></div><div class="widget-categories widget"><h4 class=widget__title>Categories</h4><div class=widget__content><ul class=widget__list><li class=widget__item><a class=widget__link href=../../../categories/dailyreport/>DailyReport</a></li><li class=widget__item><a class=widget__link href=../../../categories/learnr/>LearnR</a></li></ul></div></div><div class="widget-taglist widget"><h4 class=widget__title>Tags</h4><div class=widget__content><a class="widget-taglist__link widget__link btn" href=../../../tags/daily/ title=Daily>Daily (68)</a>
<a class="widget-taglist__link widget__link btn" href=../../../tags/research/ title=Research>Research (68)</a>
<a class="widget-taglist__link widget__link btn" href=../../../tags/week452025/ title=Week452025>Week452025 (7)</a>
<a class="widget-taglist__link widget__link btn" href=../../../tags/week462025/ title=Week462025>Week462025 (7)</a>
<a class="widget-taglist__link widget__link btn" href=../../../tags/week472025/ title=Week472025>Week472025 (7)</a>
<a class="widget-taglist__link widget__link btn" href=../../../tags/week482025/ title=Week482025>Week482025 (7)</a>
<a class="widget-taglist__link widget__link btn" href=../../../tags/week492025/ title=Week492025>Week492025 (7)</a>
<a class="widget-taglist__link widget__link btn" href=../../../tags/week502025/ title=Week502025>Week502025 (7)</a>
<a class="widget-taglist__link widget__link btn" href=../../../tags/week512025/ title=Week512025>Week512025 (7)</a>
<a class="widget-taglist__link widget__link btn" href=../../../tags/week522025/ title=Week522025>Week522025 (7)</a></div><a href=../../../tags/></a></div><div class="widget-social widget"><h4 class="widget-social__title widget__title">Social</h4><div class="widget-social__content widget__content"><div class="widget-social__item widget__item"><a class="widget-social__link widget__link btn" title=Facebook rel="noopener noreferrer" href=https://facebook.com/username target=_blank><svg class="widget-social__link-icon icon icon-facebook" width="24" height="24" viewBox="0 0 352 352"><path d="m0 32v288c0 17.5 14.5 32 32 32h288c17.5.0 32-14.5 32-32V32c0-17.5-14.5-32-32-32H32C14.5.0.0 14.5.0 32zm320 0v288h-83V212h41.5l6-48H237v-31c0-14 3.5-23.5 23.5-23.5h26V66c-4.4-.6-19.8-1.5-37.5-1.5-36.9.0-62 22.2-62 63.5v36h-42v48h42v108H32V32z"/></svg>
<span>Facebook</span></a></div><div class="widget-social__item widget__item"><a class="widget-social__link widget__link btn" title=Twitter rel="noopener noreferrer" href=https://twitter.com/username target=_blank><svg class="widget-social__link-icon icon icon-twitter" width="24" height="24" viewBox="0 0 384 312"><path d="m384 36.9c-14.1 6.3-29.3 10.5-45.2 12.4 16.3-9.7 28.8-25.2 34.6-43.6-15.2 9-32.1 15.6-50 19.1-14.4-15.2-34.9-24.8-57.5-24.8-43.5.0-78.8 35.3-78.8 78.8.0 6.2.7 12.2 2 17.9-65.5-3.3-123.5-34.6-162.4-82.3C20 26 16.1 39.6 16.1 54c0 27.3 13.9 51.4 35 65.6-12.9-.4-25.1-4-35.7-9.9v1c0 38.2 27.2 70 63.2 77.2-6.6 1.8-13.6 2.8-20.8 2.8-5.1.0-10-.5-14.8-1.4 10 31.3 39.1 54.1 73.6 54.7-27 21.1-60.9 33.7-97.8 33.7-6.4.0-12.6-.4-18.8-1.1C34.9 299 76.3 312 120.8 312c144.9.0 224.1-120 224.1-224.1.0-3.4-.1-6.8-.2-10.2 15.4-11.1 28.7-25 39.3-40.8z"/></svg>
<span>Twitter</span></a></div><div class="widget-social__item widget__item"><a class="widget-social__link widget__link btn" title=Instagram rel="noopener noreferrer" href=https://www.instagram.com/username target=_blank><svg class="widget-social__link-icon icon icon-instagram" width="24" height="24" viewBox="0 0 256 256"><circle cx="193" cy="59" r="15"/><path fill-rule="evenodd" d="M101 0h54c41 0 58.4 3.9 74.5 17C256.2 37.5 256 74.8 256 97.7v60c0 26.7.0 60.4-26.5 81.4-16 13.4-33.5 16.9-74.5 16.9h-54c-41 0-57.5-3.5-74.5-16.9C1 218.9.5 186.3.1 160.5L0 155V97.7c0-23-.2-60.2 26.5-80.7C45 2 60 0 101 0zm4.9 23h44.3c45.8.0 58.3 3.5 70.3 17.5 11.8 13.2 12 30.1 12.5 62.9V156c.2 20.8.3 45.8-12.5 59.5-12 14-24.5 17.5-70.3 17.5h-44.3c-45.9.0-57.3-3.5-70.4-17.5-12.2-13-12.3-36.5-12.4-56.7v-55.6c.4-32.6.7-49.6 12.4-62.7C48 26.5 60 23 105.9 23zm19.6 144.5a42 42 0 100-84 42 42 0 000 84zm0 22.5a64.5 64.5.0 100-129 64.5 64.5.0 000 129z"/></svg>
<span>Instagram</span></a></div></div></div></aside></div><footer class=footer><div class="container footer__container flex"><div class=footer__copyright>&copy; 2026 ç”Ÿä¿¡æ™®æ‹‰æ–¯.
<span class=footer__copyright-credits>Generated with <a href=https://gohugo.io/ rel="nofollow noopener" target=_blank>Hugo</a> and <a href=https://github.com/Vimux/Mainroad/ rel="nofollow noopener" target=_blank>Mainroad</a> theme.</span></div></div></footer></div><script async defer src=../../../js/menu.js></script><script src=../../../js/custom.js></script><script src="https://cdnjs.cloudflare.com/ajax/libs/mathjax/2.7.6/MathJax.js?config=TeX-AMS-MML_HTMLorMML" async></script></body></html>